|Title||Demonstration of sustained drug-resistant human immunodeficiency virus type 1 lineages circulating among treatment-naive individuals|
|Publication Type||Journal Article|
|Year of Publication||2009|
|Authors||Hue S, Gifford RJM, Dunn DT, Fearnhill E, Pillay D|
|Keywords||*Drug Resistance, Viral, Cluster Analysis, Great Britain, HIV Infections/*transmission/*virology, HIV-1/*drug effects/*genetics/isolation & purification, Humans, Male, Molecular Sequence Data, Phylogeny, pol Gene Products, Human Immunodeficiency Virus/genetics, Sequence Analysis, DNA|
Transmission of human immunodeficiency virus (HIV) drug resistance is well-recognized and compromises response to first-line therapy. However, the population dynamics of transmitted resistance remains unclear, although previous models have assumed that such transmission reflects direct infection from treated individuals. We investigated whether population-based phylogenetic analyses would uncover lineages of resistant viruses circulating in untreated individuals. Through the phylogenetic analysis of 14,061 HIV type 1 (HIV-1) pol gene sequences generated in the United Kingdom from both treatment-naive and -experienced individuals, we identified five treatment-independent viral clusters containing mutations conferring cross-resistance to antiretroviral drugs prescribed today in the United Kingdom. These viral lineages represent sustainable reservoirs of resistance among new HIV infections, independent of treatment. Dated phylogenies reconstructed through Bayesian Markov chain Monte Carlo inference indicated that these reservoirs originated between 1997 and 2003 and have persisted in the HIV-infected population for up to 8 years. Since our cohort does not represent all infected individuals within the United Kingdom, our results are likely to underestimate the number and size of the resistant reservoirs circulating among drug-naive patients. The existence of sustained reservoirs of resistance in the absence of treatment has the capacity to threaten the long-term efficacy of antiretroviral therapy and suggests there is a limit to the decline of transmitted drug resistance. Given the current decrease in resistance transmitted from treated individuals, a greater proportion of resistance is likely to come from drug-naive lineages. These findings provide new insights for the planning and management of treatment programs in resource-rich and developing countries.
|Short Title||Journal of virology|
|Alternate Journal||Journal of virology|